NCT05167994
- Conditions
- Anlotinib, Extremity, Intensity-modulated Radiotherapy, +7 more
- Locations
-
- Radiotherapy Department of Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
Clinical trial condition
Explore clinical trials studying Sarcoma,Soft Tissue. Study availability and eligibility vary by location and protocol.
NCT05167994
NCT04605770
NCT04577014
NCT06408441
NCT04219202
NCT04122872
NCT06835049
NCT06941194
NCT05296564
NCT07066982